P
PPCB
Propanc Bio
0.9428
-0.0472-4.77%After Hours: 0.9500 +0.0072 +0.76%19:30 09/10 EDT
OPEN/PREV CLOSE0.9734/0.9900
TODAY RANGE0.9360-0.9762
VOL129.00K
MARKET CAP3.30M
52 WEEK RANGE0.9150-62.50
AVG VOL (3M)2.79M
% TURNOVER3.56%
TURNOVER--
P/E (TTM)-0.0284
% RANGE3.95%
EPS(TTM)-33.1925
P/E(FORWARD)--
P/B2.950
BVPS0.3196
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.86M
SHARES OUTSTANDING3.50M
NEXT EARNINGS--
FREE FLOAT1.98M
LOT SIZE1
EX-DATE05/18/2026
News
Press Releases
Financial Reports
Profile
Benzinga·08/28 17:05
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·08/28 12:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga·08/28 10:31
Why Elastic Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
NASDAQ·08/27 18:52
Biotech Gainers: PPCB And CELU Lead Rally On Company-Specific Catalysts
Benzinga·08/27 17:06
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga·08/27 15:08
Revolution Medicines’ Pancreatic Cancer Drug Approval Validates Microcap Propanc Biopharma’s Breakthrough Survival Results
Benzinga·08/27 14:02
Nasdaq Surges 200 Points; Nvidia Posts Upbeat Q2 Results
TipRanks·08/27 13:47
Why Is Penny Stock Propanc Biopharma (PPCB) Up 245% Today?
TipRanks·08/27 12:45
Propanc Biopharma announces new preclinical data for PRP in PDAC
TipRanks·08/18 12:50
Propanc Biopharma starts finalization of clinical trial protocol for PRP study
TipRanks·08/17 09:24
Propanc highlights PRP as potential therapy against RAS-driven cancers
Same Industry
Name/Symbol
Change%
Price